SenesTech, Inc. (SNES)
Nasdaq · Basic Materials · Specialty Chemicals
$0.8349+7.18%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $4.4M
- 52-week range
- $0.625 – $4.45
- 52-week change
- −81.63%
- EPS (trailing)
- −$1.22
- Next earnings
- Nov 4, 2026
Fiscal year to Dec 2025
- Revenue
- $2.2M (+19.60%)
- Net income
- −$6.4M
- Operating margin
- −292.9%
- Diluted EPS
- −$1.95
- Free cash flow
- −$5.9M
From the company’s annual report on SEC EDGAR.
About SenesTech, Inc.
SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption. It also develops Evolve Mouse, a modified version of its bait technology containing the active ingredient cottonseed oil that limits reproduction of male and female mice. The company was incorporated in 2004 and is headquartered in Surprise, Arizona.
Headquarters: Surprise, United States · 23 employees · senestech.com